BYBEE CLINTON - Insider Trades & Share Buys/Sales

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for BYBEE CLINTON

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2025-10-27 Purchase	2025-10-29 7:21 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,915,700	$2.61	$4,999,977	33,847,838 (Indirect)	View
2024-04-02 Purchase	2024-04-04 4:30 pm	Boundless Bio Inc.	BOLD	CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner	200,000	$16	$3,200,000	1,181,766 (Indirect)	View
2024-02-08 Purchase	2024-02-12 5:43 pm	Sana Biotechnology Inc.	SANA	CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner	1,818,181	$5.5	$9,999,996	22,747,272 (Indirect)	View
2023-09-19 Purchase	2023-09-20 06:16 am	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,500,000	$17	$25,500,000	3,624,143 (Indirect)	View
2022-09-13 Purchase	2022-09-15 6:53 pm	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	5,000,000	$1.5	$7,500,000	13,854,098 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-04-02 Conversion	2024-04-04 4:30 pm	N/A N/A	Boundless Bio Inc.	BOLD	CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner	4,851,442	$0	1,181,766 (Indirect)	View
Ownership	2024-03-27 7:56 pm	N/A N/A	Boundless Bio Inc.	BOLD	CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner	0	$0	2,494,095 (Indirect)	View
2023-12-08 Other	2023-12-12 7:53 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,879,654	$0	32,424,564 (Indirect)	View
2023-09-19 Conversion	2023-09-20 06:16 am	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	17,424,704	$0	3,624,143 (Indirect)	View
Ownership	2023-09-14 9:29 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	0	$0	28,045,420 (Indirect)	View
2022-09-02 Other	2022-09-07 8:29 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,018	$0	1,126,748 (Indirect)	View
2022-08-30 Other	2022-09-01 5:20 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,006	$0	1,117,864 (Indirect)	View
2022-08-24 Other	2022-08-26 5:12 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,006	$0	1,109,010 (Indirect)	View
2022-08-18 Other	2022-08-22 5:14 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,503	$0	582,653 (Indirect)	View
2022-08-12 Other	2022-08-16 9:04 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,552,509	$0	1,613,232 (Indirect)	View
2022-06-08 Other	2022-06-10 9:27 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,503	$0	564,945 (Indirect)	View
2022-06-02 Other	2022-06-06 8:24 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,502	$0	10,955,581 (Indirect)	View
2021-12-20 Other	2021-12-22 5:59 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,811,207	$0	12,527,079 (Indirect)	View
2021-11-29 Other	2021-12-01 6:30 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,485	$0	12,205,620 (Indirect)	View
2021-11-22 Other	2021-11-24 5:58 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,485	$0	12,483,411 (Indirect)	View
2021-07-01 Other	2021-07-06 4:47 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	4,033,412	$0	16,277,129 (Indirect)	View
2021-06-30 Other	2021-07-02 5:19 pm	N/A N/A	Beam Therapeutics Inc.	BEAM	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner	208,052	$0	3,357,682 (Indirect)	View
2021-06-25 Other	2021-06-29 5:22 pm	N/A N/A	Beam Therapeutics Inc.	BEAM	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner	416,104	$0	3,961,048 (Indirect)	View
2021-06-22 Other	2021-06-24 5:03 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,008,348	$0	15,501,684 (Indirect)	View
2021-06-21 Conversion	2021-06-23 5:42 pm	N/A N/A	Lyell Immunopharma Inc.	LYEL	ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	54,619,074	$0	18,206,358 (Indirect)	View
Ownership	2021-06-16 9:00 pm	N/A N/A	Lyell Immunopharma Inc.	LYEL	ARCH Venture Partners IX LLC ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	0	$0	36,412,716 (Indirect)	View
2021-04-13 Other	2021-04-15 5:18 pm	N/A N/A	Karuna Therapeutics Inc.	KRTX	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner	76,264	$0	1,608,617 (Indirect)	View
2021-04-07 Other	2021-04-09 5:07 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,008,360	$0	16,064,106 (Indirect)	View
2021-03-31 Other	2021-04-02 3:19 pm	N/A N/A	Beam Therapeutics Inc.	BEAM	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	203,366	$0	3,927,319 (Indirect)	View
2021-03-30 Other	2021-04-01 5:24 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,008,350	$0	16,626,496 (Indirect)	View
2021-03-18 Other	2021-03-22 7:34 pm	N/A N/A	Beam Therapeutics Inc.	BEAM	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	406,731	$0	4,529,873 (Indirect)	View
2021-02-08 Conversion	2021-02-10 7:22 pm	N/A N/A	Sana Biotechnology Inc.	SANA	ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner	65,625,000	$0	11,718,750 (Indirect)	View
Ownership	2021-02-03 9:30 pm	N/A N/A	Sana Biotechnology Inc.	SANA	ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner	0	$0	44,042,500 (Indirect)	View

BYBEE CLINTON - Insider Trading & Ownership